ÂÜÀòÂÒÂ×

Paolo Caimi, MD is an Associate Professor of Medicine at the Cleveland Clinic Lerner College of Medicine, Staff Physician, Cleveland Clinic and Associate Director for Cell Therapy, Cleveland Clinic Taussig Cancer Center. His research is centered on the treatment of lymphoid malignancies, with specific emphasis on the implementation of early phase studies of mechanism-based therapeutic agents for lymphoma, with an additional focus on cell therapies, immunotherapy and transplantation. Dr. Caimi has completed several investigator-initiated clinical trials, including phase 1 and phase 2 studies of targeted agents in lymphoma, including trials using CAR-T cells manufactured at the point of care.